Table 1

Characteristics of the included study-subjects

Heterozygous FH
Yes n = 129No n = 127Yes versus No P
Male sex, n (%) 50 (39) 55 (43) .55 
Age, y 35 ± 9.0 42 ± 8.7 < .001 
Body mass index, kg/m2 25.0 ± 5.5 25.6 ± 4.2 .37 
Lipid profile, mmol/L    
    TC 6.1 ± 1.4 5.3 ± 1.1 < .001 
    LDL-C 4.2 ± 1.4 3.4 ± 0.9 < .001 
    HDL-C 1.5 ± 0.4 1.5 ± 0.4 .90 
    Triglycerides (IQR) 0.78 (0.59-1.13) 0.86 (0.65-1.43) .11 
Factor VIII, % 103 ± 33 95 ± 24 .039 
vWF, % 94 ± 35 99 ± 27 .23 
hsCRP (IQR), mg/L 1.2 (0.4-3.2) 1.2 (0.4-2.5) .64 
Heterozygous FH
Yes n = 129No n = 127Yes versus No P
Male sex, n (%) 50 (39) 55 (43) .55 
Age, y 35 ± 9.0 42 ± 8.7 < .001 
Body mass index, kg/m2 25.0 ± 5.5 25.6 ± 4.2 .37 
Lipid profile, mmol/L    
    TC 6.1 ± 1.4 5.3 ± 1.1 < .001 
    LDL-C 4.2 ± 1.4 3.4 ± 0.9 < .001 
    HDL-C 1.5 ± 0.4 1.5 ± 0.4 .90 
    Triglycerides (IQR) 0.78 (0.59-1.13) 0.86 (0.65-1.43) .11 
Factor VIII, % 103 ± 33 95 ± 24 .039 
vWF, % 94 ± 35 99 ± 27 .23 
hsCRP (IQR), mg/L 1.2 (0.4-3.2) 1.2 (0.4-2.5) .64 

hsCRP indicates high sensitivity C-reactive protein; IQR, borders of quartiles; HDL-C, HDL-cholesterol; LDL-C, LDL-cholesterol; TC, total cholesterol; and vWF, von Willebrand factor.

Close Modal

or Create an Account

Close Modal
Close Modal